What does european hospital liability — year 6 mean?

This metric tracks the financial performance of the European hospital liability insurance segment in the sixth year of the reporting cycle. It captures the revenue or underwriting contribution from medical malpractice and general liability coverage provided to healthcare institutions across Europe. Analyzing this figure helps stakeholders assess the segment's ability to maintain market share and manage long-term liability claims.

King Pharmaceuticals KG European Hospital Liability — Year 6

Other product segments

General Liability

10.8%—

Commercial Auto Liability

8.6%—

All other lines

-0.9%—

International

0.7%—

Similar metrics at other companies

CNAMedical Professional Liability — Year 6

9.7%+0.8pp

CNAGeneral Liability — Year 6

9.8%+0.6pp

CNAOther Professional Liability and Management Liability — Year 6

7.3%+0.4pp

ORIGeneral Liability — Year 6

8%+0.1pp

GLREHealth — Year 6

0%—

CNAMedical Professional Liability — Year 5

13.2%+0.5pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSix.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's european hospital liability — year 6.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's european hospital liability — year 6?: King Pharmaceuticals (KG) reported european hospital liability — year 6 of 8.5% in Q4 2025.
What does european hospital liability — year 6 mean?: This metric tracks the financial performance of the European hospital liability insurance segment in the sixth year of the reporting cycle. It captures the revenue or underwriting contribution from medical malpractice and general liability coverage provided to healthcare institutions across Europe. Analyzing this figure helps stakeholders assess the segment's ability to maintain market share and manage long-term liability claims.